Fingerprint
Dive into the research topics of '17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer
Joanna M Day, Paul A Foster, Helena J Tutill, Michael F C Parsons, Simon P Newman, Surinder K Chander, Gillian M Allan, Harshani R Lawrence, Nigel Vicker, Barry V L Potter, Michael J Reed, Atul Purohit
Research output: Contribution to journal › Article › peer-review
98
Citations
(Scopus)